TL;DR: Astaxanthin, used as a nutritional supplement, antioxidant and anticancer agent, prevents diabetes, cardiovascular diseases, and neurodegenerative disorders, and also stimulates immunization.
Abstract: There is currently much interest in biological active compounds derived from natural resources, especially compounds that can efficiently act on molecular targets, which are involved in various diseases. Astaxanthin (3,3'-dihydroxy-β, β'-carotene-4,4'-dione) is a xanthophyll carotenoid, contained in Haematococcus pluvialis, Chlorella zofingiensis, Chlorococcum, and Phaffia rhodozyma. It accumulates up to 3.8% on the dry weight basis in H. pluvialis. Our recent published data on astaxanthin extraction, analysis, stability studies, and its biological activities results were added to this review paper. Based on our results and current literature, astaxanthin showed potential biological activity in in vitro and in vivo models. These studies emphasize the influence of astaxanthin and its beneficial effects on the metabolism in animals and humans. Bioavailability of astaxanthin in animals was enhanced after feeding Haematococcus biomass as a source of astaxanthin. Astaxanthin, used as a nutritional supplement, antioxidant and anticancer agent, prevents diabetes, cardiovascular diseases, and neurodegenerative disorders, and also stimulates immunization. Astaxanthin products are used for commercial applications in the dosage forms as tablets, capsules, syrups, oils, soft gels, creams, biomass and granulated powders. Astaxanthin patent applications are available in food, feed and nutraceutical applications.
TL;DR: The research reviewed supports the assumption that protecting body tissues from oxidative damage with daily ingestion of natural astaxanthin might be a practical and beneficial strategy in health management.
TL;DR: Cultivation methods have been developed to produce Haematococcus containing 1.5-3.0% astaxanthin by dry weight, with potential applications as a pigment source in aquaculture, poultry feeds and in the worldwide nutraceutical market.
TL;DR: Algae are fast growing biomass and can be converted to Biodiesel fuel and need a light:dark regime for productive photosynthesis and the effect of temperature and light intensity on their growth is studied.
Abstract: Algae are fast growing biomass and can be converted to Biodiesel fuel. The demand of biodiesel is growing worldwide. Microalgae need a light:dark regime for productive photosynthesis. Light conditions and Temperature affect directly the growth rate of microalgae (duration and intensity).Literature review of some Green algae species Chlorella, Spirogyra, Chlamydomonas, Botryococcus, Scenedesmus, Neochloris, Haematococcus, Nannochloropsis, Ulva species and few species of brown algae, red algae, blue green algae were chosen to study the effect of temperature and light intensity on their growth. Optimum temperature range 20 °C to30 °C was observed for growth of different algae species. Light irradiance varies between 33 µmol m−2 s−1 to 400 µmol m−2 s−1. Maximum growth rate was found 1.73 d−1 for Selenastrum minutum at 35 °C and 420 µmol m−2 s−1 irradiance. Minimum growth rate (0.10 d−1) was reported for Botryococcus braunii KMITL 2 strain at temperature 25 °C, photoperiod 24:0 and 200 µmol m−2 s−1 irradiance.
TL;DR: The results suggest that astaxanthin synthesis proceeds via cantaxanth in Haematococcus and that this exceptional stress response is mediated by reactive oxygen species (ROS) through a mechanism which is not yet understood.
Abstract: The unicellular green alga Haematococcus pluvialis Flotow has recently aroused considerable interest due to its capacity to amass large amounts of the ketocarotenoid astaxanthin (3,3′-dihydroxy-β,β-carotene-4,4′-dione), widely used commercially to color flesh of salmon. Astaxanthin accumulation in Haematococcus is induced by a variety of environmental stresses which limit cell growth in the presence of light. This is accompanied by a remarkable morphological and biochemical ‘transformation’ from green motile cells into inert red cysts. In recent years we have studied this transformation process from several aspects: defining conditions governing pigment accumulation, working out the biosynthetic pathway of astaxanthin accumulation and questioning the possible function of this secondary ketocarotenoid in protecting Haematococcus cells against oxidative damage. Our results suggest that astaxanthin synthesis proceeds via cantaxanthin and that this exceptional stress response is mediated by reactive oxygen species (ROS) through a mechanism which is not yet understood. The results do not support in vivo chemical quenching of ROS by the pigment, although in vitro it was shown to quench radicals very efficiently. The finding that most of the pigment produced is esterified and deposited in lipid globules outside the chloroplast further supports this assumption. We have suggested that astaxanthin is the by-product of a defense mechanism rather than the defending substance itself, although at this stage one cannot rule out other protective mechanisms. Further work is required for complete understanding of this transformation process. It is suggested that Haematococcus may serve as a simple model system to study response to oxidative stress and mechanisms evolved to cope with this harmful situation.